Resultados de un estudio nacional en Suecia | 27 NOV 17
Enfermedad aterosclerótica periférica
Resultados cardiovasculares en pacientes con enfermedad arterial periférica como manifestación inicial o subsiguiente de enfermedad aterosclerótica
Autor/a: Sigvant B, Pål Hasvold P, Kragsterman B, Falkenberg M, Johansson S, Thuresson M, Nordanstig J J Vasc Surg 2017; 66(2): 507-514.e1
Página 1
- Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007;45:1185-91.
- Sigvant B, Lundin F, Wahlberg E. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg 2016;51:395-403.
- United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2013. Available at: http://www.un.org/en/development/desa/population/ publications/pdf/ageing/WorldPopulationAgeing2013.pdf. Accessed August 24, 2016.
- Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Röther J, et al; REduction of Atherothrombosis for Continued Health Registry Investigators. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J 2009;30:2318-26.
- Subherwal S, Patel MR, Kober L, Peterson ED, Bhatt DL, Gislason GH, et al. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Eur J Prev Cardiol 2015;22: 317-25.
- Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-701.
- Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 2011;124:17-23.
- Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M, et al. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. J Vasc Surg 2016;64:1009-17.e3.
- Norgren L, Hiatt WR, Harris KA, Lammer J; TASC II Working Group. TASC II section F on revascularization in PAD. J Endovasc Ther 2007;14:743-4.
- Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine, Society for Vascular Surgery. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updat
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
CONTENIDOS RELACIONADOS
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024